New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2013
05:55 EDTADUS, ADUS, ATRS, ATRS, BGMD, BGMD, DSCO, DSCO, EXPR, EXPR, GSOL, GSOL, KOPN, KOPN, PERI, PERI, SNSS, SNSSCompanies reporting Before the Market Open on Wednesday, March 13
Notable companies reporting before the opening bell on Wednesday include Addus Homecare (ADUS), Antares Pharma (ATRS), BG Medicine (BGMD), Discovery Laboratories (DSCO), Express (EXPR), Global Sources (GSOL), Kopin (KOPN), Perion Network (PERI), and Sunesis Pharmaceuticals (SNSS).
News For ADUS;ATRS;BGMD;DSCO;EXPR;GSOL;KOPN;PERI;SNSS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
05:24 EDTGSOLGlobal Sources renews contract to host trade shows at AWE for $23.2M
Global Sources has renewed its contract to host its highly successful trade shows at AsiaWorld-Expo, or AWE, in Hong Kong in 2017 and 2018 for approximately $23.1M. The company will retain the right to host its events twice a year -- in April and October -- at AWE.
December 15, 2014
16:21 EDTADUSAddus HomeCare announces CFO Meulemans to retire in 2015
Subscribe for More Information
16:20 EDTADUSAddus HomeCare names Maxine Hochhauser COO
Addus HomeCare announced the appointment of Maxine Hochhauser as COO and the promotion of Darby Anderson to Chief Business Development and Strategy Officer. Hochhauser joins Addus, from Amedisys where she was Senior Vice President, Enterprise Operations. Most recently Anderson has served as SVP to which he was promoted from VP of Home and Community Services.
10:00 EDTSNSSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:27 EDTSNSSSunesis upgraded at Roth Capital
Subscribe for More Information
06:06 EDTSNSSSunesis upgraded to Buy from Neutral at Roth Capital
Subscribe for More Information
December 10, 2014
10:20 EDTEXPROptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTSNSSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:23 EDTSNSSOn The Fly: Pre-market Movers
Subscribe for More Information
07:53 EDTPERIUBS to hold a conference
Subscribe for More Information
06:40 EDTSNSSSunesis upgraded to Buy from Hold at Cantor
Subscribe for More Information
December 8, 2014
13:34 EDTSNSSSunesis announces positive results from ongoing trial of Vosaroxin
Subscribe for More Information
12:40 EDTSNSSOn The Fly: Midday Wrap
Subscribe for More Information
10:20 EDTEXPROptions with decreasing implied volatility
Subscribe for More Information
09:29 EDTSNSSSunesis risk/reward attractive, says RBC Capital
RBC Capital believes that the EU could approve Sunesis' vosaroxin drug. The firm says that an EU approval would lift the stock by about 35%, and ir keeps a $3 price target and Sector Perform rating on the shares.
05:51 EDTSNSSSunesis to host conference call
Conference call to discuss results from the Phase 3 VALOR trial of vosaroxin and cytarabine will be held on December 9 at 1:30 pm. Webcast Link
December 7, 2014
16:42 EDTSNSSSunesis announces presentation of Phase 3 VALOR trial results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use